Our Objectives

 

To design the future

To safeguard Germany as a location for the pharmaceutical industry and to advance social security are two great challenges that politicians, the business community and society must face together.

We have accepted these challenges and are looking forward to communicating with all parties involved in this joint endeavor.

We are committed to ensuring

• that therapeutic progress will be available to all patients in Germany in the long term;
  
  
• that the entire population of our country can benefit from an efficient and financeable health care system; and
  
  
• that reliable, future-oriented general conditions will continue to facilitate the research, development and production of innovative pharmaceuticals in Germany.
  
  

Many diseases remain undefeated. Therefore, society and politicians cannot simply accept new pharmaceuticals. They must proactively demand them.